Tampa, FL – Oct 17, 2025 – RheeGen®, a pioneering leader in cell-free topical regenerative therapy, announced today a strategic partnership with Winback, a global innovator in TECAR energy and electrotherapy technologies. The collaboration aims to integrate the regenerative power of RheeGen’s topical bio-signal technology with Winback’s advanced high-frequency energy systems—offering a new era of non-invasive recovery and performance enhancement for clinicians, athletes, and patients worldwide.
RheeGen®, developed by Dr. Tommy Rhee, CEO and Founder of Physical Chiropractic of Tampa Bay, and the leading expert in topical stem cell therapy, has revolutionized the field of regenerative medicine with its proprietary transdermal delivery system. By harnessing bioactive molecules inspired by stem cell science, RheeGen® delivers targeted cellular communication and recovery without injections or invasive procedures.
Winback, led in the Americas by Matthieu Commeau, Managing Director at Winback Group, has become a global reference in TECAR therapy—using high-frequency electrical currents to accelerate tissue healing, reduce inflammation, and enhance natural biological recovery.
Through this collaboration, clinicians will be able to combine RheeGen®’s bio-regenerative topical formulations with Winback’s cutting-edge TECAR systems, creating a synergistic effect that promotes deeper cellular activation, improved microcirculation, and faster recovery outcomes.
“This partnership bridges two complementary innovations—RheeGen’s cell-free regenerative science and Winback’s energy-based technology,” said Dr. Tommy Rhee, CEO and Developer of RheeGen. “Together, we’re advancing non-invasive regenerative medicine and empowering practitioners with a powerful, science-backed solution for pain relief, performance, and repair.”
“We are thrilled to partner with Dr. Rhee and the RheeGen® team,” added Matthieu Commeau, Managing Director of Americas at Winback Group. “This collaboration aligns perfectly with our mission to enhance patient recovery through natural, innovative technologies that optimize cellular communication and accelerate healing.”
The joint initiative will include clinical integration programs, educational workshops, and research collaborations to validate combined protocols for musculoskeletal recovery, sports performance, and pain management.
For more information, visit: Media Contact:
RheeGen® Dr. Tommy Rhee CEO & Developer [email protected], www.RheeGen.com
Winback Matthieu Commeau Managing Director, Americas, [email protected], www.Winback.com
Media Contact
Company Name: At Large PR
Contact Person: Jeff Bearden
Email: Send Email
Country: United States
Website: www.atlargepr.com